journal
https://read.qxmd.com/read/38639289/transcending-molecules-paving-the-way-from-lab-to-life-in-drug-transport-innovation
#1
EDITORIAL
Abhishek Verma, Abhishek Chauhan, Ankit Awasthi
No abstract text is available yet for this article.
April 18, 2024: Current Drug Targets
https://read.qxmd.com/read/38639288/magnetomorph-the-future-of-targeted-drug-delivery
#2
EDITORIAL
Ashutosh Kumar, Ghanshyam Das Gupta, Manish Kumar
No abstract text is available yet for this article.
April 18, 2024: Current Drug Targets
https://read.qxmd.com/read/38591210/cisplatin-based-combination-therapy-for-enhanced-cancer-treatment
#3
JOURNAL ARTICLE
Qi Li, Siwei Chen, Xiao Wang, Jia Cai, Hongwu Huang, Shengsong Tang, Dongxiu He
Cisplatin, a primary chemotherapeutic drug, is of great value in the realm of tumor treatment. However, its clinical efficacy is strictly hindered by issues, such as drug resistance, relapse, poor prognosis, and toxicity to normal tissue. Cisplatin-based combination therapy has garnered increasing attention in both preclinical and clinical cancer research for its ability to overcome resistance, reduce toxicity, and enhance anticancer effects. This review examines three primary co-administration strategies of cisplatin-based drug combinations and their respective advantages and disadvantages...
April 8, 2024: Current Drug Targets
https://read.qxmd.com/read/38591209/the-recent-advances-in-the-function-and-mechanism-of-caveolin-1-in-retinal-neovascularization
#4
JOURNAL ARTICLE
Rui Zhang, Yalong Dang
Retinal neovascularization diseases have relatively high rates of evitable blindness. Abnormal retinal neovascularization is their main hallmark, which can damage the structure and function of the eye and lead to impaired vision. Caveolin-1 is a membrane protein that is expressed in many types of retinal cells and is involved in retinal neovascularization. This review presents a comprehensive analysis of global research on specific functions of caveolin-1 in retinal neovascularization. We believe that the mechanism of action of caveolin-1 might be related to the regulation of relevant signal pathways and looked ahead the application prospects of modulating caveolin- 1 in retinal neovascularization diseases...
April 5, 2024: Current Drug Targets
https://read.qxmd.com/read/38566381/drug-repurposing-using-fda-adverse-event-reporting-system-faers-database
#5
JOURNAL ARTICLE
Robert Morris, Feng Cheng, Rahinatu Ali
Drug repurposing is an emerging approach to reassigning existing pre-approved therapies for new indications. The FDA Adverse Event Reporting System (FAERS) is a large database of over 28 million adverse event reports submitted by medical providers, patients, and drug manufacturers and provides extensive drug safety signal data. In this review, four common drug repurposing strategies using FAERS are described, including inverse signal detection for a single disease, drug-drug interactions that mitigate a target ADE, identifying drug-ADE pairs with opposing gene perturbation signatures and identifying drug-drug pairs with congruent gene perturbation signatures...
April 2, 2024: Current Drug Targets
https://read.qxmd.com/read/38566380/skin-microbial-composition-and-genetic-mutation-analysis-in-precision-medicine-for-epidermolysis-bullosa
#6
JOURNAL ARTICLE
Inna Syafarina, Maulida Mazaya, Ariani Indrawati, Sharfina Zahra Akbar, Rifki Sadikin, Caecilia Sukowati
Epidermolysis bullosa (EB) is an inherited skin disease representing a spectrum of rare genetic disorders. These conditions share the common trait that causes fragile skin, resulting in the development of blisters and erosions. The inheritance follows an autosomal pattern, and the array of clinical presentations leads to significant physical suffering, considerable morbidity, and mortality. Despite EB having no cure, effectively managing EB remains an exceptional challenge due to its rarity and complexity, occasionally casting a profound impact on the lives of affected individuals...
April 1, 2024: Current Drug Targets
https://read.qxmd.com/read/38544392/genetic-factors-and-micrornas-in-the-development-of-gallbladder-cancer-the-prospective-clinical-targets
#7
JOURNAL ARTICLE
Roshani Quraishi, Medha Dwivedi, Monika Moitra, Somali Sanyal, Manish Dwivedi
Gallbladder cancer (GBC) is an uncommon condition in which malignant (cancer) cells are detected in gallbladder tissue. Cancer is often triggered when normal cells turn malignant and begin to spread. Cancer can also be caused by genetic anomalies that result in uncontrolled cell proliferation and tumor development. MicroRNAs (also known as miRNAs or miRs) are a group of small, endogenous, non-coding RNAs of 19-23 nucleotides in length, which play a key role in post-transcriptional gene regulation. These miRNAs serve as negative gene regulators by supervising target genes and regulating biological processes, including cell proliferation, migration, invasion, and apoptosis...
March 27, 2024: Current Drug Targets
https://read.qxmd.com/read/38500275/antiobesity-drug-discovery-research-in-vitro-models-for-shortening-the-drug-discovery-pipeline
#8
JOURNAL ARTICLE
Radheshyam, Priyanka Gauniya, Mona Semalty, Ajay Semalty
Obesity is a growing global health problem, leading to various chronic diseases. Despite standard treatment options, the prevalence of obesity continues to rise, emphasizing the need for new drugs. in vitro methods of drug discovery research provide a time and cost-saving platform to identify new antiobesity drugs. The review covers various aspects of obesity and drug discovery research using in vitro models. Besides discussing causes, diagnosis, prevention, and treatment, the review focuses on the advantages and limitations of in vitro studies and exhaustively covers models based on enzymes and cell lines from different animal species and humans...
March 18, 2024: Current Drug Targets
https://read.qxmd.com/read/38500274/an-overview-of-contemporary-and-future-therapeutic-strategies-for-scalp-psoriasis
#9
JOURNAL ARTICLE
Bindu Soni, Riya Shivgotra, Karan Trehan, Aashveen Chhina, Muskaan Saini, Subheet Kumar Jain, Shubham Thakur
Scalp psoriasis is a common manifestation of psoriasis that significantly impacts a patient's quality of life. About 80% of cases of psoriasis involve the scalp, making it the most frequently affected area of the body. The treatment of scalp psoriasis is particularly crucial because of its hard-to-treat nature and substantial adverse impacts on overall well-being. Along with the physical symptoms of discomfort and itching, psoriasis, especially when it affects the scalp, can cause severe psychological damage...
March 15, 2024: Current Drug Targets
https://read.qxmd.com/read/38454772/use-of-total-parenteral-nutrition-tpn-as-a-vehicle-for-drug-delivery
#10
JOURNAL ARTICLE
Hossamaldeen Bakrey, Riya Shivgotra, Abdulkadir Abdu, Bindu Soni, Navid Reza Shahtaghia, Subheet Kumar Jain, Shubham Thakur
Total Parenteral Nutrition (TPN) is a method of providing nutrients directly into the bloodstream for individuals who are unable to meet their nutritional needs through the normal digestive process or gastrointestinal system. It provides macronutrients and micronutrients in a single container, reducing handling and contamination risks and making it more cost-effective. TPN has the potential to be used as a drug delivery system, with applications in combination therapies, personalized medicine, and integrating advanced technologies...
March 6, 2024: Current Drug Targets
https://read.qxmd.com/read/38424432/xerostomia-advances-and-challenges-in-drug-development
#11
EDITORIAL
Yoon-Jung Kim
No abstract text is available yet for this article.
February 28, 2024: Current Drug Targets
https://read.qxmd.com/read/38409709/surface-functionalized-lipid-nanoparticles-in-promoting-therapeutic-outcomes-an-insight-view-of-the-dynamic-drug-delivery-system
#12
JOURNAL ARTICLE
Namish Manchanda, Harish Vishkarma, Muskan Goyal, Saurabh Shah, Paras Famta, Sushama Talegaonkar, Saurabh Srivastava
Compared to the conventional approach, nanoparticles (NPs) facilitate a non-hazardous, non-toxic, non-interactive, and biocompatible system, rendering them incredibly promising for improving drug delivery to target cells. When that comes to accomplishing specific therapeutic agents like drugs, peptides, nucleotides, etc., lipidic nanoparticulate systems have emerged as even more robust. They have asserted impressive ability in bypassing physiological and cellular barriers, evading lysosomal capture and the proton sponge effect, optimizing bioavailability, and compliance, lowering doses, and boosting therapeutic efficacy...
February 22, 2024: Current Drug Targets
https://read.qxmd.com/read/38385490/current-insights-into-carpal-tunnel-syndrome-clinical-strategies-for-prevention-and-treatment
#13
JOURNAL ARTICLE
Rishabh Chaudhary, Janvi Khanna, Seema Bansal, Nitin Bansal
BACKGROUND: Carpal tunnel syndrome (CTS) is a condition that is caused by medial nerve compression, resulting in symptoms such as numbness, tightness, or weakness in the hand. OBJECTIVES: The aim of the study was to find out the genetic modulation, mechanism, available treatment, and recommendation for carpal tunnel syndrome at its specific stage. METHODS: Almost 200 papers were searched for this review article, and 145 articles were selected...
February 21, 2024: Current Drug Targets
https://read.qxmd.com/read/38375843/recent-advances-in-biomedical-applications-of-mannans-and-xylans
#14
JOURNAL ARTICLE
Shriya Teli, Kajal Deshmukh, Tabassum Khan, Vasanti Suvarna
Plant-based phytochemicals, including flavonoids, alkaloids, tannins, saponins, and other metabolites, have attracted considerable attention due to their central role in synthesizing nanomaterials with various biomedical applications. Hemicelluloses are the second most abundant among naturally occurring heteropolymers, accounting for one-third of all plant constituents. In particular, xylans, mannans, and arabinoxylans are structured polysaccharides derived from hemicellulose. Mannans and xylans are characterized by their linear configuration of β-1,4-linked mannose and xylose units, respectively...
February 19, 2024: Current Drug Targets
https://read.qxmd.com/read/38288834/quantum-dot-based-bio-conjugates-as-an-emerging-bioimaging-tool-for-cancer-theranostic-a-review
#15
JOURNAL ARTICLE
Lipika Priya, Smit Mehta, Darshan Gevariya, Raghav Sharma, Drishti Panjwani, Shruti Patel, Priyanka Ahlawat, Abhay Dharamsi, Asha Patel
Cancer is the most widely studied disorder in humans, but proper treatment has not yet been developed for it. Conventional therapies, like chemotherapy, radiation therapy, and surgery, have been employed. Such therapies target not only cancerous cells but also harm normal cells. Conventional therapy does not result in specific targeting and hence leads to severe side effects. The main objective of this study is to explore the QDs. QDs are used as nanocarriers for diagnosis and treatment at the same time. They are based on the principle of theranostic approach...
January 29, 2024: Current Drug Targets
https://read.qxmd.com/read/38258779/deciphering-neuroprotective-effect-of-rosmarinus-officinalis-l-syn-salvia-rosmarinus-spenn-through-preclinical-and-clinical-studies
#16
JOURNAL ARTICLE
Ibukun O Oresanya, Ilkay Erdogan Orhan
Rosmarinus officinalis L. (RO, rosemary) is a well-known medicinal, aromatic, and culinary herb with traditional use in European folk medicine against memory deficits and neurodegenerative disorders. This review highlights the different neuroprotective activities of RO investigated in both preclinical and clinical studies, as well as in silico molecular docking of bioactive compounds found in RO. The neuroprotective effect of RO was searched through databases including PubMed, Web of Science (WoS), Scopus, and Clinical Trials using the keywords "Rosmarinus officinalis, rosemary, neuroprotective effect, memory, cognitive dysfunction, Alzheimer's disease...
January 22, 2024: Current Drug Targets
https://read.qxmd.com/read/38231060/an-updated-insight-into-phytomolecules-and-novel-approaches-used-in-the-management-of-breast-cancer
#17
JOURNAL ARTICLE
Zulfa Nooreen, Sudeep Tandon, Ankita Wal, Awani Kumar Rai
Breast cancer is a widespread condition that kills more women from cancer-related causes than any other type of cancer globally. Women who have estrogen-dependent, initial metastatic breast cancer frequently receive treatment with surgery, radiation therapy, and chemotherapy. They may also get more specialized treatments like tamoxifen or aromatase inhibitors (anastrozole or letrozole). The World Health Organisation reported in 2012 that by 2030, breast cancer will be more common worldwide. There are several phytochemicals, such as isoflavones, coumestans, lignans, and prenylflavonoides...
January 12, 2024: Current Drug Targets
https://read.qxmd.com/read/38213165/efficacy-and-possible-mechanisms-of-astragali-radix-and-its-ingredients-in-animal-models-of-osteoporosis-a-preclinical-review-and-metaanalysis
#18
Ning Cao, Zhangxuan Shou, Yi Xiao, Puqing Liu
BACKGROUND: Astragali Radix (AR) has a long history as a traditional Chinese medicine for anti-osteoporosis (OP) treatment. The aim of the study was to explore the effect and optimal regimens of AR and its main ingredients (IAR) in OP treatment. METHODS: Eligible animal studies were searched in seven databases (PubMed, Web of Science, MEDLINE, SciELO Citation Index, Cochrane Library, China National Knowledge Infrastructure and Wanfang). The primary outcomes were bone metabolic indices...
January 11, 2024: Current Drug Targets
https://read.qxmd.com/read/38213164/a-review-on-the-recent-advancements-and-artificial-intelligence-in-tablet-technology
#19
JOURNAL ARTICLE
Amit Sahu, Sunny Rathee, Shivani Saraf, Sanjay K Jain
BACKGROUND: Tablet formulation could be revolutionized by the integration of modern technology and established pharmaceutical sciences. The pharmaceutical sector can develop tablet formulations that are not only more efficient and stable but also patient-friendly by utilizing artificial intelligence (AI), machine learning (ML), and materials science. OBJECTIVES: The primary objective of this review is to explore the advancements in tablet technology, focusing on the integration of modern technologies like artificial intelligence (AI), machine learning (ML), and materials science to enhance the efficiency, cost-effectiveness, and quality of tablet formulation processes...
January 11, 2024: Current Drug Targets
https://read.qxmd.com/read/38213163/targeting-protein-phosphatases-for-the-treatment-of-chronic-liver-disease
#20
JOURNAL ARTICLE
Yi-Ming Li, Hong-Wei He, Na Zhang
There exists a huge number of patients suffering from chronic liver disease worldwide. As a disease with high incidence and mortality worldwide, strengthening the research on the pathogenesis of chronic liver disease and the development of novel drugs is an important issue related to the health of all human beings. Phosphorylation modification of proteins plays a crucial role in cellular signal transduction, and phosphatases are involved in the development of liver diseases. Therefore, this article summarized the important role of protein phosphatases in chronic liver disease with the aim of facilitating the development of drugs targeting protein phosphatases for the treatment of chronic liver disease...
January 11, 2024: Current Drug Targets
journal
journal
35111
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.